INS and type 2 diabetes mellitus: Among the alkaloids, III demonstrated the most potent activity in PTP-1B inhibition, which supports further development of III as a novel PTP-1B inhibitor that may serve as “insulin sensitizer” in the management of type 2 diabetes.